ESR1 and neoplasm: The change in ER expression in our study could potentially contribute to the debatable explanations about this phenomenon and support the encouragement of re-assessing the hormonal status of tumours and metastases during the progression of the disease (Schrijver et al., 2018; Bernsdorf, 2011).